In colorectal cancer patients, higher dietary insulin scores after colorectal cancer diagnosis were associated with a statistically significant increase in colorectal cancer-specific and overall mortality, indicating poorer survival [53,55], and reduced mortality after breast cancer diagnosis [54]. The gene discussed is INS; the disease is breast carcinoma.